RD Gelber
- Oncology top 2%
- HER2/EGFR in Cancer Research 14
- Cancer Treatment and Pharmacology 7
- Neutropenia and Cancer Infections 3
- Cancer Research top 2%
- Breast Cancer Treatment Studies 21
- Hematology top 5%
- Acute Myeloid Leukemia Research 3
-
- Lymphoma Diagnosis and Treatment 3
-
- Advanced Breast Cancer Therapies 13
-
- Estrogen and related hormone effects 8
- Co-authors
- J R AndersonKevin C. CainAron GoldhirschCarl‐Magnus RudenstamRastko GolouhJennifer StylesRichard ReedB.A. Gusterson
- Cited by
- OncologyCancer ResearchHematology
- Journals
- Cancer Research (10 papers)Journal of Clinical Oncology (5 papers)Annals of Oncology (5 papers)
- Partner nations
- SwitzerlandItalyUnited States
In The Last Decade
RD Gelber
33 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 1.7k
- Cancer Research 909
- Hematology 315
- Radiology, Nuclear Medicine and Imaging 465
- Pathology and Forensic Medicine 325
Countries citing papers authored by RD Gelber
This map shows the geographic impact of RD Gelber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RD Gelber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RD Gelber more than expected).
Fields of papers citing papers by RD Gelber
This network shows the impact of papers produced by RD Gelber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RD Gelber. The network helps show where RD Gelber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside RD Gelber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2017 | 16 | |
| 3 | 2016 | 8 | |
| 4 | 2013 | 15 | |
| 5 | 2012 | 0 | |
| 6 | 2011 | 65 | |
| 7 | 2007 | 106 | |
| 8 | 2007 | 20 | |
| 9 | 2003 | 29 | |
| 10 | 2003 | 5 | |
| 11 | 2000 | 212 | |
| 12 | 1998 | 12 | |
| 13 | 1997 | 15 | |
| 14 | 1997 | 107 | |
| 15 | 1992 | 71 | |
| 16 | Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.breakdown → | 1992 | 698 |
| 17 | 1990 | 31 | |
| 18 | 1990 | 73 | |
| 19 | 1988 | 36 | |
| 20 | 1983 | 2 |
About RD Gelber
RD Gelber is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Genetics and Pathology and Forensic Medicine, having authored 37 papers that have together received 2.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (21 papers), HER2/EGFR in Cancer Research (14 papers), Advanced Breast Cancer Therapies (13 papers), Estrogen and related hormone effects (8 papers), Cancer Treatment and Pharmacology (7 papers), Acute Myeloid Leukemia Research (3 papers), Neutropenia and Cancer Infections (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (909 citations), Hematology (315 citations), Radiology, Nuclear Medicine and Imaging (465 citations) and Pathology and Forensic Medicine (325 citations). RD Gelber has collaborated with scholars based in Switzerland, Italy and United States. Frequent co-authors include J R Anderson, Kevin C. Cain, Aron Goldhirsch, Carl‐Magnus Rudenstam, Rastko Golouh, Jennifer Styles, Richard Reed, B.A. Gusterson, Rajakumar Anbazhagan and Karen N. Price. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Annals of Oncology, The Breast and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.